Oncotarget · 2017 · 28 citations · 33 references
Life SciencesCell BiologyGeneticsCancer GeneticsMolecular OncologyProteomicsMitochondrial SignalingOxidative Stress In CarcinogenesisBap1 LossBap1 Tumor Predisposition SyndromeCell Motility ModulationMass Spectrometry ProteomicsRos1 OncogeneTumor Cell MotilityTumor Suppressor Pathways
// Lucie Hebert 1 , Dorine Bellanger 1 , Chloé Guillas 1 , Antoine Campagne 2 , Florent Dingli 3 , Damarys Loew 3 , Alice Fievet 1, 4 , Virginie Jacquemin 1 , Tatiana Popova 1 , Didier Jean 5 , Fatima Mechta-Grigoriou 1 , Raphaël Margueron 2 and Marc-Henri Stern 1, 4 1 Department of Genetics and Biology of Cancers, INSERM U830, Institut Curie, PSL Research University, Paris 75248, France 2 Department of Developmental Biology and Genetics, CNRS UMR 3215/INSERM U934, Institut Curie, PSL Research University, Paris 75248, France 3 Mass Spectrometry and Proteomics facility, Institut Curie, PSL Research University, Paris 75248, France 4 Department of Genetics, Institut Curie, Paris 75248, France 5 INSERM UMR-1162, Paris 75010, France Correspondence to: Marc-Henri Stern, email: marc-henri.stern@curie.fr Keywords: BAP1, tumor suppressor, de-ubiquitination, proteomics, protein stability Received: October 29, 2016     Accepted: July 23, 2017     Published: August 03, 2017 ABSTRACT The tumor suppressor BAP1 associates with ASXL1/2 to form the core Polycomb complex PR-DUB, which catalyzes the removal of mono-ubiquitin from several substrates including histone H2A. This complex also mediates the poly-deubiquitination of HCFC1, OGT and PCG1-α, preventing them from proteasomal degradation. Surprisingly, considering its role in a Polycomb complex, no transcriptional signature was consistently found among BAP1 -inactivated tumor types. It was hypothesized that BAP1 tumor suppressor activity could reside, at least in part, in stabilizing proteins through its poly-deubiquitinase activity. Quantitative mass spectrometry and gene expression arrays were used to investigate the consequences of BAP1 expression modulation in the NCI-H226 mesothelioma cell line. Analysis of differentially expressed proteins revealed enrichment in cytoskeleton organization, mitochondrial activity and ROS management, while gene expression analysis revealed enrichment in the epithelial-to-mesenchymal transition pathway. Functional assessments in BAP1 inactivated, BAP1 wild-type and BAP1 catalytically dead-expressing NCI-H226 and QR mesothelioma cell lines confirmed alteration of these pathways and demonstrated that BAP1 deubiquitinase activity was mandatory to maintain these phenotypes. Interestingly, monitoring intracellular ROS levels partly restored the morphology and the mitochondrial activity. Finally, the study suggests new tumorigenic and cellular functions of BAP1 and shows for the first time the interest of studying the proteome as readout of BAP1 inactivation.
33
Frequent Mutation of <i>BAP1</i> in Metastasizing Uveal Melanomas
J. William Harbour, Michael D. Onken, Elisha Roberson et al. · Science · 2010 · 1.5K citations · Full text
Germline BAP1 mutations predispose to malignant mesothelioma
Joseph R. Testa, Mitchell Cheung, Jianming Pei et al. · Nature Genetics · 2011 · 1.1K citations · Full text
Life Sciences, Genetics, Oncology +12
BAP1 loss defines a new class of renal cell carcinoma
Samuel Peña‐Llopis, Silvia Vega-Rubín-de-Celis, Arnold Liao et al. · Nature Genetics · 2012 · 995 citations · Full text
Medicine, Cancer Biology, Oncology +13